Search Results - "Nokam, Ghislain"

Fibromuscular dysplasia of cervical and intracranial arteries by Touzé, Emmanuel, Oppenheim, Catherine, Trystram, Denis, Nokam, Ghislain, Pasquini, Marta, Alamowitch, Sonia, Hervé, Dominique, Garnier, Pierre, Mousseaux, Elie, Plouin, Pierre-Franςois

“…Fibromuscular dysplasia is an uncommon, segmental, nonatherosclerotic arterial disease of unknown aetiology. The disease primarily affects women and involves…”
Get full text

Epilepsy in the Sanaga‐Mbam valley, an onchocerciasis‐endemic region in Cameroon: electroclinical and neuropsychological findings by Morin, Alexandre, Guillaume, Maxime, Ngarka, Leonard, Tatah, Godwin Y., Siewe Fodjo, Joseph Nelson, Wyart, Guillaume, Nokam, Ghislain, Tchoumi, Thierry, Nkinin, Mary Bello, Njamnshi, Wepnyu Y., Chokote, Eric‐Samuel, Boussinesq, Michel, Colebunders, Robert, Chesnais, Cédric B., Gargala, Gilles, Parain, Dominique, Njamnshi, Alfred K.

“…Objective Epilepsy is highly prevalent in onchocerciasis‐endemic African regions. Various types of epilepsy have been described in such regions based…”
Get full text

Efficacy of vinblastine in central nervous system Langerhans cell histiocytosis: a nationwide retrospective study by Ng Wing Tin, Sophie, Martin-Duverneuil, Nadine, Idbaih, Ahmed, Garel, Catherine, Ribeiro, Maria, Parker, Judith Landman, Defachelles, Anne-Sophie, Lambilliotte, Anne, Barkaoui, Mohamed, Munzer, Martine, Gardembas, Martine, Sibilia, Jean, Lutz, Patrick, Fior, Renato, Polak, Michel, Robert, Alain, Aumaitre, Olivier, Plantaz, Dominique, Armari-Alla, Corinne, Genereau, Thierry, Berard, Perrine Marec, Talom, Ghislain Nokam, Pennaforte, Jean-Loup, Le Pointe, Hubert Ducou, Barthez, Marie-Anne, Couillault, Gérard, Haroche, Julien, Mokhtari, Karima, Donadieu, Jean, Hoang-Xuan, Khê

“…Vinblastine (VBL) is the standard treatment for systemic Langerhans cell histiocytosis (LCH), but little is known about its efficacy in central nervous system…”
Get full text

Reasons for switching to fingolimod in patients relapsing-remitting multiple sclerosis in France: the ESGILE study by Tourbah, Ayman, Papeix, Caroline, Tourniaire, Patricia, Rerat, Karin, Meite, Mohamed, Durand, Barbara, Lamy, Fabienne, Chouette, Isabelle, Mekies, Claude

“…•Disease worsening is the principal reason for switching to fingolimod•Patient preferences enter into the decision in one-third of cases•Whatever the reason…”
Get full text